Continuous Versus Intermittent Subglottic Secretion Drainage to Prevent Ventilator-Associated Pneumonia: A Systematic Review.

Crit Care Nurse

Zunjia Wen is a registered nurse at The First Affiliated Hospital of Soochow University, Suzhou, China. Haiying Zhang is an associate professor at The First Affiliated Hospital of Soochow University, Suzhou, China. Jianping Ding is a registered nurse at The First Affiliated Hospital of Soochow University, Suzhou, China. Zhuo Wang is a registered nurse at The First Affiliated Hospital of Soochow University, Suzhou, China. Meifen Shen is a professor at The First Affiliated Hospital of Soochow University, Suzhou, China.

Published: October 2017

Background: Ventilator-associated pneumonia is associated with high morbidity and mortality in patients receiving mechanical ventilation. Subglottic secretion drainage, which may be performed continuously or intermittently, is believed to be an effective strategy for coping with ventilator-assisted pneumonia. Whether continuous or intermittent subglottic secretion drainage is superior for preventing ventilator-assisted pneumonia remains unknown.

Methods: This study is a comprehensive, systematic meta-analysis of randomized trials comparing continuous and intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Studies in English and Chinese published from January 1970 through November 2015 were identified by searching multiple databases. Summary risk ratios or weighted mean differences with 95% CIs were used to calculate each outcome by means of fixed- or random-effects models.

Results: Eight studies enrolling a total of 1071 patients met the inclusion criteria. The summary risk ratio between continuous and intermittent subglottic secretion drainage for incidence of ventilator-assisted pneumonia was 0.83 (95% CI, 0.61-1.13); for time to ventilator-assisted pneumonia occurrence, 2.73 (95% CI, -0.39 to 5.85); for occult blood, 2.34 (95% CI, 0.25-21.88); for duration of mechanical ventilation, -0.89 (95% CI, -2.72 to 0.94); for length of intensive care unit stay, 3.98 (95% CI, -4.44 to 12.41); and for mortality, 0.80 (95% CI, 0.48-1.31).

Conclusions: The results indicate no apparent differences between continuous and intermittent subglottic secretion drainage for the treatment outcomes included in the analysis. Rigorously designed, large-scale randomized controlled trials are warranted to identify the roles of continuous and intermittent subglottic secretion drainage.

Download full-text PDF

Source
http://dx.doi.org/10.4037/ccn2017940DOI Listing

Publication Analysis

Top Keywords

subglottic secretion
28
secretion drainage
28
intermittent subglottic
24
continuous intermittent
20
ventilator-assisted pneumonia
16
mechanical ventilation
12
ventilator-associated pneumonia
8
patients receiving
8
receiving mechanical
8
summary risk
8

Similar Publications

Subglottic stenosis poses a rare but life-threatening risk for difficult tracheal intubation. Here, we report a unique case of undiagnosed subglottic stenosis discovered during emergency intubation of an 80-year-old woman with type 2 respiratory failure from infective exacerbation of asthma. A small calibre size 5.

View Article and Find Full Text PDF

[Clinical characteristics of 6 cases of relapsing polychondritis in children with airway involvement].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi

November 2024

Department of Otorhinolaryngology Head and Neck Surgery, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing Key Laboratory for Pediatric Diseases of Otolaryngology Head and Neck Surgery, National Center for Children's Health(NCCH), Beijing100045, China.

To investigate the pathogenesis, clinical signs and diagnosing procedures of relapsing polychondritis(RP) in children with airway involvement. The medical history, clinical symptoms, physical examination, electronic laryngoscopy and imaging findings of six patients were retrospectively analyzed. The patients diagnosed as relapsing polychondritis with involving the airway from January 2018 to December 2021 were in our hospital.

View Article and Find Full Text PDF

Primary Subglottic Laryngeal Tuberculosis Mimicking as Malignancy: A rare case Report.

Indian J Otolaryngol Head Neck Surg

December 2024

Deptt of Otorhinolaryngology and head and neck surgery, GMC, Rajindra Hospital, Patiala, India.

Article Synopsis
  • Primary laryngeal tuberculosis is rare, with less than 1% incidence, while secondary laryngeal TB is more common and typically originates from the lungs.
  • The case described involves a 31-year-old woman with persistent throat irritation, hoarseness, and mild respiratory issues, ultimately diagnosed with primary subglottic tuberculosis.
  • This case is noteworthy due to the rarity of primary laryngeal TB, which can sometimes be mistaken for cancer.*
View Article and Find Full Text PDF

To explore the complications of long-term placement of Montgomery T silicone stent (Ttube) in the treatment of subglottic benign airway stenosis (SBAS) and the timing of successful Ttube removal. We retrospectively collected the clinical data of 32 patients with SBAS who underwent the treatment of Ttube and analyzed their placement and successful removal of the Ttube. There were 22 males and 10 females, aged from 21 to 79 years (60.

View Article and Find Full Text PDF

ANCA-negative granulomatosis polyangiitis: an airway emergency.

BMJ Case Rep

September 2024

Department of ENT, Salford Care Organisation, Northern Care Alliance NHS foundation Trust, Salford, UK

Article Synopsis
  • - Granulomatosis polyangiitis (GPA) is a rare autoimmune disorder that inflames small blood vessels, potentially affecting various body parts, and is often challenging to diagnose due to the possibility of negative antibodies and inconclusive biopsy results.
  • - A case study is presented of a patient who faced an airway emergency due to nasal cavity inflammation, with a negative ANCA test and inconclusive tissue biopsy results, leading to urgent treatment requiring airway dilatation and a regimen of cyclophosphamide.
  • - Over more than 4 years of follow-up, the patient has shown no relapse of symptoms, illustrating the importance of comprehensive clinical management for this serious condition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!